Australia seems poised to welcome innovative treatment for weight issues: Retatrutide. This dual molecule – acting on both GLP-1 and GIP receptors – demonstrates promising efficacy in clinical trials, suggesting considerable decreases in body fat. While regulatory clearance hasn't occurred with Australian regulators, many people battling being … Read More